Message from Top management

Sanwa Kagaku Kenkyusho is striving to become the best partner for diabetes treatment as a one-stop provider of total solution for diabetics.

We, Sanwa Kagaku Kenkysho, are research-based company devoting ourselves to development of medicines that provide “new value” to the people who wish to improve their well-being.

Sanwa Kagaku Kenkyusho is a specialty pharmaceutical company focused on diabetes and diabetes-related diseases allocating a significant portion of its resources.

I believe that our main three business divisions, Pharmaceutical, Diagnostic and Nutrition Business make us a leading one-stop provider serving total solution for the diabetics.

With a success of SEIBULE®tab. in Japan, now we are developing another diabetic pipeline in domestic and overseas markets. By co-development and out-licensing it with big pharmas, Sanwa Kagaku Kenkyusho is making a progressive approach to the global market.

We will continue to pursue our mission: “Providing human-friendly medicine to the world.” as keeping a common viewpoint of the public to get your sincere support.

Kazuo Yamamoto President & CEO Sanwa Kagaku Kenkyusho Co., Ltd.